Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020

NEXT STORY
North Americaportable oxygen concentratorsmarket is expected to reach US$ 1,315.42 million by 2027 from US$ 682.73 million in 2019
PREV STORY
Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with ...

author_avatar
NASDAQ Market News

Innate Pharma announces publication of a review article in Nature

author_avatar
NASDAQ Market News

Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL

82% (41 of 50) of patients achieved complete remission or complete remission with incomplete ...

author_avatar
NASDAQ Market News